Medico Remedies Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Medico Remedies Limited generated cash of $26,827,000, which is less than the previous year. Cash used in financing activities reached the amount of -$4,900,000 last year. Net change in cash is therefore -$7,287,000.
Cash Flow
| 2016 | -37.28M | 3.17M | 22.45M |
|---|---|---|---|
| 2018 | 50.96M | -49.76M | -6.19M |
| 2020 | 9.67M | -30.81M | 25.97M |
| 2021 | 26.08M | -751.82K | -3.50M |
| 2023 | 81.67M | -66.03M | -18.17M |
| 2024 | 26.82M | -27.70M | -4.9M |
MEDICO.NS Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 9.11M | 11.65M | 6.48M | 1.64M | 7.06M | 18.21M |
Operating activities | ||||||
Net income | 82.90M | 72.41M | 25.91M | 16.30M | 18.72M | 18.71M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 28.79M | 27.20M | 16.51M | 16.63M | 10.04M | 11.81M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -136.13M | -55.61M | -274.3M | 51.80M | 11.07M | -121.77M |
Inventories | 33.61M | -15.91M | 37.08M | -21.89M | -47.67M | -9.99M |
Accounts payable | 5.26M | 38.89M | -10.54M | -61.18M | 58.01M | 22.13M |
Cash generated by operating activities | 26.82M | 81.67M | 26.08M | 9.67M | 50.96M | -37.28M |
Investing activities | ||||||
Purchases Of Investments | -975K | -868K | -3.92M | -3.20M | -6.07M | 0 |
Investments In Property Plant And Equipment | -24.78M | -65.92M | -21.36M | -33.28M | -7.94M | -2.97M |
Acquisitions Net | 0 | -45K | 0 | 30K | 0 | 0 |
Cash generated by investing activities | -27.70M | -66.03M | -751.82K | -30.81M | -49.76M | 3.17M |
Financing activities | ||||||
Common Stock Issued | 0 | 0 | 41.5M | 0 | 90.73M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -12.18M | -32.41M | 3.58M | -86.49M | 31.06M |
Cash used in financing activities | -4.9M | -18.17M | -3.50M | 25.97M | -6.19M | 22.45M |
Net Change In Cash | -7.28M | -2.53M | 21.82M | 4.83M | -4.99M | -11.66M |
Cash at end of period | 1.82M | 9.11M | 28.30M | 6.48M | 2.06M | 6.55M |
| Data source | Data source | Data source | Data source | Data source | Data source |